| Income Statement |
| Total Revenue | 102.84M |
|
| Revenues (USD) | 102.84M |
| Cost of Revenue | 39.95M |
| Gross Profit | 62.90M |
| Operating Expenses | 42.12M |
| Research and Development Expense | 1.66M |
| Selling, General and Administrative Expense | 34.53M |
| Operating Income | 20.77M |
| Interest Expense | 1.96M |
| Income Tax Expense | 3.51M |
| Net Income | 15.40M |
| Net Income Common Stock | 15.40M |
| Net Income Common Stock (USD) | 15.40M |
| Consolidated Income | 15.91M |
| Net Income to Non-Controlling Interests | 506.00K |
| Earnings per Basic Share | 0.28 |
| Earnings per Basic Share (USD) | 0.28 |
| Earnings per Diluted Share | 0.27 |
| Earning Before Interest & Taxes (EBIT) | 20.87M |
| Earning Before Interest & Taxes (USD) | 20.87M |
| Weighted Average Shares | 54.95M |
| Weighted Average Shares Diluted | 56.57M |
| Balance Sheet |
| Cash and Equivalents | 159.92M |
| Cash and Equivalents (USD) | 159.92M |
| Investments | 215.86M |
| Trade and Non-Trade Receivables | 114.56M |
| Property, Plant & Equipment Net | 238.95M |
| Total Assets | 917.90M |
| Total Debt | 282.64M |
| Total Liabilities | 467.47M |
| Accumulated Retained Earnings (Deficit) | -230.82M |
| Accumulated Other Comprehensive Income | -7.05M |
| Shareholders Equity | 355.89M |
| Shareholders Equity (USD) | 355.89M |
| Total Debt (USD) | 282.64M |
| Deferred Revenue | 53.24M |
| Goodwill and Intangible Assets | 75.56M |
| Inventory | 39.24M |
| Trade and Non-Trade Payables | 22.51M |
| Tax Assets | 12.47M |
| Tax Liabilities | 12.52M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 15.68M |
| Net Cash Flow from Financing | -11.51M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 13.92M |
| Capital Expenditure | -6.10M |
| Issuance (Purchase) of Equity Shares | -2.27M |
| Issuance (Repayment) of Debt Securities | -8.81M |
| Net Cash Flow from Investing | -6.10M |
| Net Cash Flow from Operations | 31.99M |
| Effect of Exchange Rate Changes on Cash | -449.00K |
| Share Based Compensation | 7.38M |